#+HashtagPLUS
In

Menu

Post image 1
Post image 2
Post image 3
Post image 4
Post image 5
Post image 6
Post image 7
Post image 8
Post image 9
Post image 10
Post image 11
Post image 12
Post image 13
Post image 14
Post image 15
Post image 16
Post image 17
Post image 18
Post image 19
Post image 20
Post image 21
Post image 22
Post image 23
Post image 24
Post image 25
Post image 26
Post image 27
Post image 28
Post image 29
Post image 30
1 / 30
0

Shionogi pill prevents COVID-19 in household exposure study

The Japan Times·Jason Gale·19 days ago
#h5L5Dlge
#shionogi#covid19#pharmaceuticals#medicine#iranwarendgame#covid
Reading 0:00
15s threshold

Shionogi's pharmaceutical research center in the city of Toyonaka, Osaka Prefecture. The firm's COVID-19 pill cut the risk of infection among people exposed to the disease at home, according to a recent study. | Bloomberg An experimental COVID-19 pill developed by Japan's Shionogi cut the risk of infection among people exposed to the disease at home, according to a study that could revive interest in antivirals as a preventive tool. In a late-stage trial of more than 2,000 household contacts, 2.9% of those given Shionogi’s once-daily pill ensitrelvir developed symptomatic COVID-19 within 10 days, compared with 9.0% on placebo — a roughly two-thirds reduction in risk. The study, published Wednesday in The New England Journal of Medicine, tested a five-day course started within 72 hours after a household member fell ill. Participants were initially virus-negative and most had some prior immunity through vaccination or earlier infection.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.

Create free accountLog in
Read More